Alpha Tau Medical Analyst Ratings
Alpha Tau Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/29/2023 | 603.36% | Cantor Fitzgerald | → $23 | Reiterates | Overweight → Overweight |
| 08/18/2023 | 175.23% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/24/2023 | 175.23% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/18/2023 | 175.23% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/15/2023 | 175.23% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 04/24/2023 | 175.23% | HC Wainwright & Co. | → $9 | Initiates Coverage On | → Buy |
| 11/23/2022 | 266.97% | Piper Sandler | $19 → $12 | Maintains | Overweight |
| 04/14/2022 | 511.62% | Cantor Fitzgerald | → $20 | Initiates Coverage On | → Overweight |
| 04/08/2022 | 481.04% | Piper Sandler | → $19 | Initiates Coverage On | → Overweight |
| 04/04/2022 | 542.2% | Citigroup | → $21 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月29日 | 603.36% | 康託·菲茨傑拉德 | →$23 | 重申 | 超重→超重 |
| 2023年08月18日 | 175.23% | HC Wainwright公司 | →$9 | 重申 | 購買→購買 |
| 2023年05月24日 | 175.23% | HC Wainwright公司 | →$9 | 重申 | 購買→購買 |
| 2023年05月18日 | 175.23% | HC Wainwright公司 | →$9 | 重申 | 購買→購買 |
| 2023年05月15日 | 175.23% | HC Wainwright公司 | →$9 | 重申 | 購買→購買 |
| 04/24/2023 | 175.23% | HC Wainwright公司 | →$9 | 開始承保 | →購買 |
| 2022年11月23日 | 266.97% | 派珀·桑德勒 | $19→$12 | 維護 | 超重 |
| 04/14/2022 | 511.62% | 康託·菲茨傑拉德 | →$20 | 開始承保 | →超重 |
| 04/08/2022 | 481.04% | 派珀·桑德勒 | →$19 | 開始承保 | →超重 |
| 04/04/2022 | 542.2% | 花旗集團 | →$21 | 開始承保 | →購買 |
What is the target price for Alpha Tau Medical (DRTS)?
Alpha Tau Medical(DRTS)的目標價格是多少？
The latest price target for Alpha Tau Medical (NASDAQ: DRTS) was reported by Cantor Fitzgerald on August 29, 2023. The analyst firm set a price target for $23.00 expecting DRTS to rise to within 12 months (a possible 603.36% upside). 7 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2023年8月29日報道了阿爾法頭醫療公司(納斯達克：DRTS)的最新目標價。這家分析公司將目標價定為2300美元，預計DRTS將在12個月內升至(可能上漲603.36%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Alpha Tau Medical (DRTS)?
Alpha Tau Medical(DRTS)的最新分析師評級是什麼？
The latest analyst rating for Alpha Tau Medical (NASDAQ: DRTS) was provided by Cantor Fitzgerald, and Alpha Tau Medical reiterated their overweight rating.
阿爾法頭醫療(納斯達克股票代碼：DRTS)的最新分析師評級由坎託·菲茨傑拉德提供，阿爾法頭醫療重申其增持評級。
When is the next analyst rating going to be posted or updated for Alpha Tau Medical (DRTS)?
Alpha Tau Medical(DRTS)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alpha Tau Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alpha Tau Medical was filed on August 29, 2023 so you should expect the next rating to be made available sometime around August 29, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與阿爾法塔醫療公司的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Alpha Tau Medical的上一次評級是在2023年8月29日提交的，因此您應該預計下一次評級將在2024年8月29日左右的某個時候提供。
Is the Analyst Rating Alpha Tau Medical (DRTS) correct?
分析師對Alpha Tau Medical(DRTS)的評級正確嗎？
While ratings are subjective and will change, the latest Alpha Tau Medical (DRTS) rating was a reiterated with a price target of $0.00 to $23.00. The current price Alpha Tau Medical (DRTS) is trading at is $3.27, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的阿爾法頭醫療(DRTS)評級被重申，目標價在0.00美元至23.00美元之間。Alpha Tau Medical(DRTS)目前的交易價格為3.27美元，在分析師的預測範圍內。